🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

‼️Just Out‼️One more masterpiece of MOUSEION Project. SR and Meta-Analysis with mRCC patients evaluating the oncologic outcomes with ICI-Combos according to metastatic sites. Congrats all authors Andrey Soares Francesco Massari Matteo Santoni veronica mollica link.springer.com/article/10.100…

Typically Brazilian Crab….. 🦀

Is QoL increased with ARPI alone in #aHSPC? LACOG0415 did not show QoL improvement. Short follow-up and questionnaires were crucial, but others issues remain an open question: Are the actual questionnaires outdated? QoL really improve with ARPI alone? jamanetwork.com/journals/jaman…

Preparing to ASCO GU 2025….. Amazing bike ride…. 57 miles on the outskirts of San Francisco….:

Lutecio en #prostatecancer #GU25 ASCO 🟢 Sinergias esperadas: iPARPs, IO, ARSI 🟠 Blancos dif PSMA: CAFs, TAMs, TILs, kallikreins 🔴 Selección: imagen vintage no ayuda, el consumo de PMSA impacta, RECIP 1.0 criteria UroTeragLATAM Danny Mena - nuclear medicine

Could the use of PPI, ATB, Insulin and Corticosteroids impair the outcomes of mUC patients during EV txt? Just out our RWE addressing this practice issue! ARON project Matteo Santoni Francesco Massari Shilpa Gupta Andrey Soares Martín Angel Maite Bourlon link.springer.com/content/pdf/10…

‼️Just Out at CancerMedicine ‼️one more piece of ARON project . RWE showing the efficacy of EV in heavily treated mUC patients. Matteo Santoni Francesco Massari Andrey Soares Shilpa Gupta Enrique Grande Maite Bourlon Javier Molina Cerrillo Lazar Popovic onlinelibrary.wiley.com/doi/10.1002/ca…

Very necessary and helpful algorithm.

An Amazing meeting reaching all critical issues of Theranostics in Uro-Oncology.

An important initiative of ARON Project! A few minutes of your time that can help a lot of patients worldwide! Roula Almufti رُلى المفتي Cristiane D Bergerot Bárbara Melão, MD, PhD Vedang Murthy د.فهد عبدالعزيز المقبل

‼️Just Out at Scientific Reports one more important RWE of ARON-2 Database. Sex as modifier of OS in mUC patients treated with ICI. Congrats all authors. Matteo Santoni Francesco Massari joaquim bellmunt Lorena Incorvaia ARON project nature.com/articles/s4159…

Molecular characterization of metastatic penile squamous cell carcinoma in developing countries and its impact on clinical outcomes: LACOG 2018 translational study Fernando Sabino, MD, PhD doi.org/10.1093/oncolo…

🚨Just Out Our RWE. The efficacy and safety of Pembro+Len in mRCC patients of our daily practice. Interesting and very helpful data.ARON project Matteo Santoni Francesco Massari Camillo Porta Andrey Soares Maite Bourlon Enrique Grande link.springer.com/article/10.100…

Ready for tomorrow for the 1st International ARON Meeting ARON project Matteo Santoni Javier Molina Cerrillo

Amazing project….. Brilliant team!

Pembro/Axi vs. Nivo/Cabo as first-line therapy in mRCC patients. Out now another important experience by ARON project OncoDaily IKCC Kidney Cancer Kidney Cancer

Renal Registry (LACOG 1120) reveals major disparities in kidney cancer care in Brazil: 5-yr OS is 79.6% (private) vs. 42% (public). Patients in the public system face later diagnoses, less access to novel therapies & worse outcomes. #ASCO25 #LACOG @ascocancer

70yrs Gentleman, ECOG 1, Intestinal Adenocarcinoma of JEG - staging IV (lymph node exclusively). CPS = 20. CLDN18.2 positive. HER-2 negative. pMMR. Which systemic treatment would you prefer)? Kohei shitara Yelena Y. Janjigian MD